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Cancer cells utilize large amounts of ATP to sustain growth, relying primarily on non-oxidative, fermentative
pathways for its production. In many types of cancers this leads, even in the presence of oxygen, to the secretion
of carbon equivalents (usually in the form of lactate) in the cell’s surroundings, a feature known as the Warburg
effect. While the molecular basis of this phenomenon are still to be elucidated, it is clear that the spilling
of energy resources contributes to creating a peculiar microenvironment for tumors, possibly characterized by
a degree of toxicity. This suggests that mechanisms for recycling the fermentation products (e.g. a lactate
shuttle) may be active, effectively inducing a mutually beneficial metabolic coupling between aberrant and non-
aberrant cells. Here we analyze this scenario through a large-scale in silico metabolic model of interacting
human cells. By going beyond the cell-autonomous description, we show that elementary physico-chemical
constraints indeed favor the establishment of such a coupling under very broad conditions. The characterization
we obtained by tuning the aberrant cell’s demand for ATP, amino-acids and fatty acids and/or the imbalance
in nutrient partitioning provides quantitative support to the idea that synergistic multi-cell effects play a central
role in cancer sustainment.
INTRODUCTION
At heart, a cell’s energetic problem consists in selecting
how to process nutrients (say, glucose molecules) into chem-
ical energy (adenosine 5’-triphosphate, ATP) that will then
be transduced into useful forms of mechanical or chemical
work. Rapid cellular growth, in specific, requires high rates
of macromolecular biosynthesis and of energy production,
which presupposes (a) fast ATP generation, and (b) tight con-
trol of the cell’s redox state, i.e. that the ratio between the
levels of electron donors and acceptors stays in a range that
guarantees functionality. Most often, molecular oxygen is the
primary electron acceptor in cells, playing a central role in the
electron transfer chain (ETC) that constitutes the main ATP-
producing mechanism in cells. When a glucose molecule en-
ters the cell, it is normally metabolized by glycolysis, a highly
conserved reaction pathway that converts each glucose anaer-
obically into two molecules of pyruvate, with the concomi-
tant production of 2 ATPs. In presence of oxygen, cells can
operate the ETC, which begins with the conversion of pyru-
vate into acetyl-coenzyme-A (acetyl-CoA). The reaction path-
ways responsible for the subsequent production of ATP (and
of many macromolecular precursors like amino-acids) are the
Tricarboxylic Acid (TCA) cycle and Oxidative Phosphoryla-
tion (OXPHOS). These complex groups of reactions (roughly
100 processes altogether in the bacterium E. coli) are able to
generate the largest energy yield in terms of molecules of ATP
produced per glucose molecule intaken (up to 36, adding to
the 2 given by glycolysis), and release carbon dioxide as a
waste product. In absence of oxygen, however, cells cannot
rely on the ETC and the ATP yield of glycolysis (2) is to a
good approximation all the energy they can generate. In such
conditions, the pyruvate obtained from glycolysis is then re-
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duced to other carbon compounds (e.g. acetate, ethanol, lac-
tate) that are normally excreted in variable amounts. The con-
version of pyruvate to lactate, is carried out by a single reac-
tion catalyzed by the enzyme lactate dehydrogenase (LDH).
The energy-generating strategies just described are, in a
sense, the two extremes, and cells usually operate mixtures
of the two even in presence of oxygen, leading to ATP yields
below the theoretical maximum of 38 (typically around 30).
However, fast proliferating cells normally display high rates
of glucose intake and produce ATP anaerobically even in the
presence of oxygen, thereby spilling potentially useful carbon
and energy resources. A hint about why a large glucose in-
flux may favor the use of lower-yield pathways is provided
by the fact that processing high glucose fluxes via glycolysis
requires high rates of production of adenosine 5’-diphosphate
(ADP) and of NAD+, via oxidation of NADH. The simplest
way to convert NADH back into NAD+ is by reduction of
pyruvate to lactate via LDH. Therefore sustaining high rates
of glucose metabolization may imply lactate overflow. This
however seems to suggest that a cell with a large glucose in-
take should always prefer to generate energy by glycolysis.
Therefore, different constraints (physical, regulatory, thermo-
dynamic, etc.) may be at work in the selection of a cell’s ener-
getic strategy [1]. We note that recent high-throughput studies
of the compounds secreted by growing bacteria in controlled
environments (the so-called exo-metabolome) uncovered that,
besides the standard outputs of overflow metabolism, a pre-
viously unsuspected diversity of molecules accompanies the
excretion of carbon equivalents [2].
Likewise, aerobic glycolysis with lactate overflow (a.k.a.
Warburg effect) is found to occur in many types of cancers
[3, 4], although it cannot be considered as a necessary signa-
ture of malignancy [5]. In order to explain its predominance
at the molecular level, several ideas have been pursued, from
structural or genetic abnormalities in the mitochondria [6], to
the roles played by the hypoxia-inducible factor (HIF) [7] and
by a specific isoform of the glycolytic enzyme pyruvate ki-
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2nase [8], to seemingly unrelated genetic events leading to the
increase of glucose transporters and the loss of growth con-
trol in cancer cells [9]. The search for a molecular basis of
the Warburg effect has given momentum to the idea that treat-
ments targeting the simpler energy-producing apparatus of a
cell (as opposed to its complex and not entirely known ge-
netic profile) carry a higher potential than gene-based thera-
pies [10]. Unluckily, our understanding of cancer metabolism
is still largely incomplete [11, 12], and research on the role
of metabolism in tumor genesis and progression is currently
undergoing a major revival [13].
Cell-autonomous models of cellular metabolism based on
genome-scale reconstructions of the underlying network of
metabolic reactions have been widely studied, proving effec-
tive in explaining the origin of overflow metabolism in differ-
ent contexts. Constraint-based approaches like Flux-Balance
Analysis (FBA), for instance, have shed light on the roles that
different types of constraints may play in driving the selection
of energetic strategies towards aerobic glycolysis. An interest-
ing and intuitively appealing suggestion is put forward by the
macromolecular crowding scenario [14], according to which
enzymes carrying out energy-efficient pathways can at most
occupy a fraction of the intracellular volume (e.g. the mito-
chondria in eukaryotes). Because reactions are assumed to be
enzyme-limited, the activity of aerobic pathways will neces-
sarily level out once all deputed enzymes work at full speed,
while that of glycolysis may still increase. These models are
indeed able to predict carbon excretion by unicellulars [15]
as well as the Warburg effect in cancer cells [14, 16]. Many
issues however deserve further analysis.
One in particular concerns the fact that cellular waste prod-
ucts such as lactate tend to deteriorate the extracellular envi-
ronment, so that the sustainability of aerobic glycolysis de-
pends crucially on the possibility that such a pollution is re-
mediated within cancer’s microenvironment. This raises ques-
tions about the role of tumor-stroma metabolic interactions.
Tumors are universally characterized by a marked upregula-
tion of glucose transporters [9, 17], which allows them to
largely surpass their non-aberrant (stromal) neighbors in the
competition for nutrients. As a consequence, stromal cells
must adjust their energetics in ways that have only started to
be analyzed [18].
Lactate exchanges are increasingly being recognized to
play an important role in this respect. In a scenario that
has been characterized by genetic signatures over the past
few years, tumor-derived lactate can be taken up by glucose-
starved cancer-associated fibroblasts (CAFs) [19], which
would then both help their own survival and foster cancer’s
aberrant growth by sanitizing the environment. Here we
present a quantitative in silico analysis of the above mecha-
nism. Our results confirm that tumor-to-stroma lactate shut-
tling appears as a robust consequence of basic physical and
chemical constraints, in a manner that is largely independent
of (i) the metabolic function (e.g. energy production, amino-
acid synthesis, fatty acid synthesis, etc.) that aberrant cells
strive to maximize and, perhaps more surprisingly, (ii) of the
degree to which they manage to maximize it. The core of
our conclusions can already be reached through a highly sim-
plified model of metabolism that captures the bare essential
features of the mechanism. The intuition is then validated on
a large-scale model of catabolism based on recent reconstruc-
tions of the human reactome. After characterizing the network
at the cell-autonomous level, we consider a system formed by
two such networks sharing the same glucose supply, focusing
on the case in which one cell aims to maximize a growth-
related objective function (e.g. energy production) with the
other subject to a simple ATP maintenance constraint. The
emerging scenario is studied by tuning the ‘degree of max-
imization’ by the aberrant cell through a rigorous sampling
scheme that provides a statistically significant description of
all feasible metabolic phenotypes compatible with the con-
straints. Lactate overflow and functional tumor-stroma cou-
pling appears robustly upon maximizing production of ATP
as well as of several biomass precursors.
It is important to stress that a tumor-to-stroma coupling,
while compatible with the observation that the vast majority
of cancer cells display glycolytic metabolism, is not the only
lactate-based shuttling postulated to be relevant for tumor pro-
gression (see e.g. [20]). Other mechanisms and their relation
to the current study are outlined in the Discussion.
The remainder of the manuscript is organized as follows.
The Results section begins with a brief summary of a styl-
ized single-cell model of aerobic glycolysis presented in [14],
where it is shown how a crowding constraint can divert ATP
production from oxidative phosphorylation to fermentation.
The simple model is then extended to two cells whereby the
extent of lactate shuttle is computed analytically. A large scale
metabolic network of the human core metabolism (HCCN) is
then introduced. A rigorous sampling of the metabolisms pro-
duced by HCCN confirms the possibility of cell coupling by
means of lactate shuttle between a cancer cell and a stromal
cell. The rigorous samplings allows us to compute the corre-
lation coefficients among the fluxes of the cancer and stromal
cell. In the Discussion section, experimental evidences for
lactate shuttle are presented and, finally, physiological impli-
cations and possible experimental validation of the results are
discussed.
RESULTS
Metabolic fluxes and crowding constraint in a minimal
cell-autonomous model
Our starting point is the highly simplified cell-autonomous
model defined in [14], in which lactate secretion is related
to an ad hoc constraint limiting volume available for energy
production in cells that maximize the ATP output flux. In par-
ticular, when ATP demands exceed the volume allocated for
ATP production, the cell produces ATP also through fermen-
tation. In the model of Vazquez et al., a cell is characterized
by a glucose intake flux UG,in, a glycolytic flux fglyc (yield-
ing two pyruvate molecules per intaken glucose) and an over-
3all mitochondrial OXPHOS flux fox that transforms pyruvate
into energy (a table summarizing the most relevant variables
defined here is given as Table S1). Alternately, pyruvate can
be turned into lactate by lactate dehydrogenase (LDH), with
flux fLDH. Lactate can then be expelled from the cell so as
to avoid acidification. Mass balance and steady state condi-
tions impose that metabolite levels do not change in time, so
that, for example, the net production and consumption fluxes
of pyruvate must compensate, implying
2fglyc − fox − fLDH = 0 , (1)
(note that, to make the subsequent analysis simpler, our alge-
bra differs slightly in numerical pre-factors from the one given
in [14]. The overall picture is however completely equivalent).
The glycolytic flux is in turn limited by the flux UG that sup-
plies glucose to the system, so that UG,in ≤ UG, while under
mass balance UG,in = fglyc. The crowding constraint is im-
plemented as Vglyc + Vox + VLDH ≤ VATP, where VATP rep-
resents the cell volume devoted to ATP production, whereas
Vglyc, Vox, and VLDH are the volumes taken up by the gly-
colytic, OXPHOS, and LDH enzymes, respectively. Introduc-
ing the constants aglyc, aox, and aLDH representing the vol-
ume occupied per unit of ATP production by glycolytic, OX-
PHOS and LDH enzymes, respectively, this can be re-cast as
[14]
aglycfglyc + aoxfox + aLDHfLDH ≤ ΦATP , (2)
where ΦATP is the volume fraction available for ATP produc-
tion in each cell. Using (1), one obtains(
aLDH +
aglyc
2
)
fLDH+
(
aox +
aglyc
2
)
fox ≤ ΦATP . (3)
We shall adhere to [14] in employing the empirical estimates
aglyc ' 3× 10−3 (min/mM), aLDH ' 4.6× 10−4 (min/mM),
aox ' 2 × 10−1 (min/mM), and ΦATP = 0.4. Equation (3)
represents the “crowding constraint”, amounting to a global
constraint to the overall flux of metabolites the cell can invest
in ATP production. To be consistent with [14], we derived the
crowding constraint on fluxes by limiting the volume fraction
devoted to energy production, but the constraint (3) might as
well be derived by limiting the amount of proteins (see, e.g.,
[16]).
To assess the amount of ATP produced by these fluxes, we
consider that fglyc generates 2 ATPs and 2 pyruvates per glu-
cose molecule, and that fox creates 18 ATP molecules from
each pyruvate. The conversion of pyruvate to lactate does not
generate any ATP and it only ensures that glycolysis can con-
tinue by regenerating NADH to NAD. The overall flux of ATP
production is finally given by
fATP = 2fglyc + 18fox . (4)
Vazquez et al’s results can be summarized as follows. Ne-
glecting (3), ATP production is maximized when fglyc = UG,
fox = 2fglyc = 2UG, and fLDH = 0, i.e. when all available
glucose is taken up by the cell and used in OXPHOS. This
solution still holds if (3) is satisfied, i.e. as long as
(2aox + aglyc)UG ≤ ΦATP . (5)
If however UG > ΦATP/ (2aox + aglyc) ≡ uG, then the
cellular resources available for high-yield energy production
pathways has been exhausted and ATP synthesis is no longer
limited by glucose but by intracellular resources (either vol-
ume or proteins production capacity). Its maximization now
requires that the glucose flux exceeding the possibility of pro-
cessing by OXPHOS is diverted towards LDH. The maximum
ATP production flux and the corresponding lactate flux for this
case can be obtained by inserting fLDH = 2UG − fox into (3)
with the constraint saturated. One gets
fLDH =
{
0 if UG ≤ uG
αox(UG − uG) if UG > uG , (6)
αox =
2aox + aglyc
aox − aLDH > 0
and
fox =
{
2UG if UG ≤ uG
αLDH(vG − UG) if UG > uG , (7)
αLDH =
2aLDH + aglyc
aox − aLDH > 0
where vG = ΦATP/ (2aLDH + aglyc). Because of mass bal-
ance, fLDH also equals the lactate excretion flux so that the
Warburg effect is described by (6), which shows the existence
of a threshold glucose intake above which lactate is secreted.
Metabolic fluxes in a minimal model of two cells coupled via a
lactate shuttle
Let us now consider two replicas of Vazquez et al.’s cell
and assume that the two cells can interact via the exchange
of lactate, which, in particular, can be intaken and used as
an alternative carbon source through reverse LDH (catalyzing
the conversion of lactate back to pyruvate). For sakes of sim-
plicity, we distinguish between a donor cell (‘don’, which can
only excrete lactate) and an acceptor cell (‘acc’, which can
both excrete and import lactate) (see Fig. 1). In order to avoid
starvation, we furthermore impose that both cells generate a
minimum flux fminATP of ATP, i.e.
fATP,i ≥ fminATP , i ∈ {acc,don} (8)
where the ATP production flux is given by (4), namely
fATP,i = 2fglyc,i + 18fox,i i ∈ {acc,don} . (9)
As shown in the beginning of the previous section, when
fglyc = UG and fox = 2UG cells can extract the maximum
ATP from a single glucose molecule, i.e., fATP,i = 38UG.
We observe that, in order to satisfy (8), the overall glucose
supply to the system composed of two cells should satisfy
UG ≥ 2f
min
ATP
38
≡ 2uG,0 , (10)
4FIG. 1. Schematic representation of the minimal model of two
cells coupled via a lactate shuttle. Two cells (lactate donor and
acceptor, respectively) share glucose as an energy source. Glucose
is partitioned according to the fluxes fglyc,don and fglyc,acc, which
convert one internal glucose molecules to two pyruvate molecules
producing two ATP molecules. Pyruvate can then undergo oxida-
tive phosphorylation (with the irreversible fluxes fox,don and fox,acc,
giving 36 more ATP molecules) or LDH (with fluxes fLDH,don and
fLDH,acc, by which lactate (L) is obtained). Lactate is for simplic-
ity assumed to be secreted upon production. If both cells produce
lactate, no coupling sets in, unless due to competition for nutrients
under glucose limitation. If however the donor cell secretes lactate,
the acceptor cell may intake it to replace glucose whenever its access
to the latter is limited (e.g. because the donor cell’s glucose intake
is large). In such cases a lactate shuttle will effectively couple the
metabolisms of the two cells.
which defines uG,0 as the minimum glucose supply flux
that can prevent cellular starvation. Denoting as UG,don the
amount of glucose available to the donor cell, if the donor cell
maximizes ATP production, its flux organization will match
the one found above for a single cell. It is useful to distin-
guish two limiting cases:
(a) If the donor cell employs OXPHOS exclusively, which
happens when 2uG,0 ≤ UG ≤ uG + uG,0, we have
UG,don = UG − uG,0 and UG,acc = uG,0. In other
words, the donor cell takes up all of the available glu-
cose except for the amount necessary for the survival of
the acceptor cell. In these conditions, the acceptor cell’s
survival is guaranteed by glucose availability.
(b) At the other extreme, if the acceptor cell can survive
even using exclusively the lactate excreted by the donor
cell, all glucose is intaken by the donor cell, so that
UG,don = UG and UG,acc = 0. This happens when
fLDH,don ≥ fminATP/18, or
UG ≥ f
min
ATP
18αox
+ uG . (11)
In intermediate situations, the amount of glucose intaken by
the acceptor cell gradually decreases from uG,0 to 0 as it in-
creasingly uses lactate to produce pyruvate and thus ATP. In
such cases, the oxidative pathway of the acceptor cell is fed
by both glucose and lactate fluxes as fox,acc = 2fglyc,acc +
fLDH,don, which, via mass balance, implies (see (9))
fATP,acc = 38fglyc,acc+18fLDH,don = 38UG,acc+18fLDH,don .
(12)
To obtain simpler expressions, it is useful to introduce the
shorthands
uG,1 = uG,0 + uG , (13)
uG,2 =
fminATP
18αox
+ uG , (14)
and ∆UG for the amount of glucose rerouted from the accep-
tor cell to the donor cell, so that
UG,acc = uG,0 −∆UG
UG,don = UG − uG,0 + ∆UG . (15)
Substituting UG,acc and imposing minimal ATP requirement
in (12), we obtain
fLDH,don =
38
18
∆UG . (16)
Since the donor cell maximizes ATP production, we obtain
a second expression for fLDH,don as a function of ∆UG by
substituting UG,don: in (6)
fLDH,don = αox(UG,don−uG) = αox(UG−uG,0+∆UG−uG) .
This, combined with (16), determines the extra amount of glu-
cose available to the donor cell
∆UG =
αox
38/18− αox [UG − uG,0 − uG] . (17)
Expression (17) is valid if uG,1 < UG ≤ uG,2. For UG ≤
uG,1 one has ∆UG = 0, while when UG > uG,2 ∆UG =
uG,0. We can therefore summarize the fluxes for the donor
cell as
fLDH,don =

0 if 2uG,0 ≤ UG ≤ uG,1
αox(UG + ∆UG − uG,1) if uG,1 < UG ≤ uG,2
αox(UG − uG) if UG > uG,2
(18)
and
fox,don =

2(UG − uG,0) if 2uG,0 ≤ UG ≤ uG,1
αLDH(vG − UG,don) if uG,1 < UG ≤ uG,2
αLDH(vG − UG) if UG > uG,2
.
(19)
Because the donor cell uses up most of the glucose, the ac-
ceptor cell stays at the minimum ATP production rate fminATP
for UG ≤ uG,2. In this regime, the fluxes of the acceptor cell
are fixed and can be derived from the ones of the donor cell.
One gets
fLDH,acc =
{
0 if 2uG,0 ≤ UG ≤ uG,1
−fLDH,don if uG,1 < UG ≤ uG,2 (20)
5FIG. 2. Qualitative behaviour of the single-cell and of the donor-
acceptor system for the coarse-grained model. (a) In the cell-
autonomous model, lactate overflow occurs when the glucose intake
overcomes a threshold. Correspondingly, the flux through oxidative
metabolism increases until the threshold before slowly decreasing
once the crowding constraint is saturated and fermentation sets in.
(b) In the donor/acceptor system, the donor behaves essentially as an
autonomous cell and the acceptor adapts to it. For low glucose in-
takes, it operates oxidative pathways at small rate. When the donor
saturates the crowding constraint excreting lactate, the acceptor im-
ports it and uses it at a substrate to increase the flux through oxidative
metabolism.
and
fox,acc =
{
2uG,0 if 2uG,0 ≤ UG ≤ uG,1
2UG,acc + fLDH,don if uG,1 < UG ≤ uG,2 .
(21)
For large total glucose intakes, the donor cell excretes more
lactate than necessary for bare survival of the acceptor cell,
which can produce any amount of ATP as long as it is larger
than fminATP. The metabolic state of the acceptor cell is there-
fore not uniquely defined. When UG ≥ uG,2, for the fluxes of
the acceptor cell one finds
−fLDH,don ≤ fLDH,acc ≤ −f
min
ATP
38
(22)
fox,acc = −fLDH,acc , (23)
while the ATP production is given by
fATP,acc = −18fLDH,acc . (24)
Note that fLDH,acc < 0 because the acceptor cell intakes lac-
tate and reverses LDH.
The solution to this model is described pictorially in Fig. 2
and discussed in Fig. 3, where we also show the feasible range
of values of the fluxes of the acceptor cell.
In essence, this coarse-grained model suggests that an im-
balance in the energetic demands of two cells can induce a
metabolic coupling driven by a lactate shuttle from the high-
to the low-demand cell, and provides a qualitative scenario
for how carbon utilization in both cells changes by tuning the
overall glucose supply. We shall now see that such a pic-
ture is fully recovered within a large-scale model of human
metabolism.
Metabolic fluxes and crowding constraint in a cell-autonomous
large scale metabolic network
In order to characterize the exchange of carbon equivalents
among interacting cells more in detail, we have analyzed a
human metabolic network derived from the reconstructed hu-
man reactome [21], to which we refer as the ‘Human Core
Catabolic Network’ (HCCN, see ‘Materials and Methods’).
The HCCN is composed by 67 metabolites and 75 reactions
(including uptake fluxes), 23 of which are reversible. The
crowding constraint that accounts for finite cellular resources
is represented as
aglycfHEX + aox(fPDH + fGLUN) + aLDHfLDH ≤ ΦATP
(25)
where fHEX denotes the Hexokinase-1 flux, which irre-
versibly channels glucose into glycolysis, fPDH denotes the
flux through pyruvate dehydrogenase, by which pyruvate is
diverted into the TCA cycle and fGLUN denotes the mithocon-
drial flux of nitrogen metabolism through glutaminase. We
explore the space of flux patterns consistent with the con-
straints by sampling solutions of the mass balance equations
Sf = 0 (S denoting the stoichiometric matrix and f being a
flux vector) such that flux vectors fdon of the donor cell ap-
pear with probability
P (fdon) = A exp[βfATP,don] , (26)
where β ≥ 0 is a parameter and A is a normalization con-
stant. The rationale is that, by tuning the value of β, we can
pass from an unbiased sampling in which fATP,don takes on
every allowed value with uniform probabilty (β = 0) to one
in which the donor cell maximizes its ATP output (β → ∞),
thereby obtaining a complete and refined picture of how dif-
ferent degrees of optimization by the donor cell impact the
flux pattern of the acceptor cell. Solutions at the two extremes
can be obtained with standard methods, as linear program-
ming, but only our method allows us to sample realistic sub-
optimal optimizations. In Fig. S6 we show how the ATP pro-
duction increases as a function of β. In the following, as a
prototype for sub-optimal optimization, we choose β = 5 that
corresponds to roughly 70% of the maximum ATP production.
Model and algorithmic details are discussed in ‘Materials and
Methods’.
In Fig. 4a we show the ATP production of a single HCCN
cell as a function of the available glucose. If ATP produc-
tion is maximized (large β), one first encounters a regime
with a yield of roughly 30 ATPs per glucose molecule (to be
compared with the theoretical value of 38) and then a regime
where the yield is about 1.7 ATPs per glucose. ATP is pro-
duced by OXPHOS in the former case, and by fermentation
in the latter (see also Fig. 4b and Fig. 4c). As expected, net-
works maximizing ATP shift their metabolic strategy at the
glucose intake for which the resources available for ATP pro-
duction by oxidation is exhausted. Note that for β = 5 one
obtains an ATP efficiency very close to optimal. Quite im-
portantly and surprisingly, however, for β = 0 (i.e. when
no ATP maximization is performed) the emerging picture is
qualitatively preserved, albeit with lower ATP yields. Indeed
6FIG. 3. Solution of the minimal model of two cells coupled via a lactate shuttle. A lactate donor cell that maximizes ATP production is
coupled to an acceptor cell. (a) Glucose intake for donor and acceptor as a function of total glucose supply. (b) ATP production as a function of
the total glucose supply. The shaded area indicates that all values within that region are feasible. (c) Flux through fermentation fLDH (circles)
and oxidative phosphorylation fox (crosses) as a function of the total glucose supply. (d) Fraction of ATP produced via fermentation (black)
or via oxidative phosphorylation (red) in the donor cell as a function of the total ATP it produces.
solutions sampled at β = 0 appear to employ a mixture of
OXPHOS and fermentation even at low glucose intakes. It is
remarkable that the resources-driven shift still occurs at uG,
as in this case it corresponds to a largely suboptimal value
of ATP production. In other words, the HCCN might devote
cellular resources to increase ATP production, but to do so
it must explicitly be pursuing ATP maximization. This im-
plies that the crossover from a high- to a low-yield strategy is
a robust, embedded property of the network (and of the con-
straints imposed) and not an exclusive characteristic of the ex-
tremal solution that maximizes the ATP production.
In Fig. 4b, we focus on the fluxes through PDHm and LDH,
that indicate whether pyruvate is directed towards OXPHOS
or fermentation. We see that high ATP yields are obtained
by using OXPHOS exclusively. The typical network state at
β = 0 is less efficient at all glucose intakes, as it always di-
verts a larger fraction of pyruvate to fermentation compared
to the ATP-maximizing cell. Finally, in Fig. 4c, we detail how
glucose partitions between fermentation and OXPHOS. The
network displays a reversal of glucose fate as the crowding
constraint is saturated independently of whether ATP produc-
tion is being maximized or not. The latter case however turns
out to be generically less efficient.
Metabolic fluxes in a large scale metabolic network of two cells
coupled via a lactate shuttle
We now consider two replicas of the HCCN and again dis-
tinguish between a lactate acceptor and a donor cell. We also
impose that there is no external lactate source, and explore
the scenario where the donor optimizes ATP production to a
degree tuned by the parameter β. Fig. 5a shows that, as ex-
pected, an ATP-maximizing donor cell sequesters all of the
available glucose except for the small amount required for the
acceptor’s survival. This is reflected by the ATP production
curves as a function of the total glucose supply displayed in
Fig. 5b. In such conditions, the acceptor’s ATP production
fluxes matches the minimum required for survival, i.e. fminATP
(which is set to be equal to 1 uG for simplicity) until the donor
switches to aerobic glycolysis, thereby excreting lactate. The
donor, on the other hand, goes through an initial phase of ex-
clusive OXPHOS use, followed by a switch to aerobic glycol-
ysis when the crowding constraint does not allow for a further
increment of the mitochondrial flux. In Fig. 6a one indeed
sees that glucose is mainly channeled to OXPHOS as long as
the crowding constraint allows for it. As soon as the latter is
saturated, the donor diverts pyruvate to LDH, usefully regen-
erating NAD from NADH and thus avoiding glycolysis halt.
LDH generates lactate, which is then expelled and intaken by
the acceptor. As shown in Fig. 6b, this is accompanied by a
7FIG. 4. An isolated HCCN maximizes the ATP yield by directing
glucose to OXPHOS even in absence of an active ATP maximiza-
tion. (a) Average ATP production as a function of the re-scaled av-
erage glucose supply. (b) Average flux through LDH (crosses) and
PDHm (circles) as a function of the re-scaled average glucose sup-
ply. (c) Fraction of ATP produced via glycolysis (crosses) or via
OXPHOS (circles) as a function of the re-scaled total ATP produced.
The flux through each pathway is re-scaled by half the amount of glu-
cose intaken by the cell (because with one molecule of glucose cells
produce two molecules of pyruvate). Curves describe the behaviour
of an ATP-maximizing HCCN (black lines, β = 50), a loosely max-
imizing donor (red lines, β = 5) or the result of a uniform sampling
of the allowed flux states for a HCCN (blue lines, β = 0). Error bars
for the s.e.m. are smaller than symbols.
FIG. 5. When a lactate donor maximizes its ATP production it
intakes most of the glucose supplied to the two-cell system. The
ATP production by the acceptor cell increases in correspondence
to a decrease in efficiency of the donor’s metabolism. (a) Glu-
cose intakes for two coupled cells as a function of the total glucose
available to the donor-acceptor pair. (b) ATP produced by the donor.
Curves describe the behaviour obtained for two coupled HCCN cells
with an ATP-maximizing donor (black lines, β = 50), a loosely
maximizing donor (red lines, β = 5) or for an unbiased sampling of
the two-cell solution space (blue lines, β = 0). Error bars for the
s.e.m. are smaller than symbols.
reversal of LDH in the acceptor: lactate is transformed into
pyruvate that is then channeled to OXPHOS through PDHm.
The acceptor can thus spare some cellular resources to pro-
duce pyruvate, at the cost of becoming strongly dependent on
the donor for ATP production.
If one instead averages over all solutions without biasing
for ATP production by setting β = 0, the two cells produce
comparable amounts of ATP and share glucose more evenly
(see Fig. 5a). The fact that the donor turns out to employ
slightly more glucose than the acceptor is due to the intrin-
sic asymmetry that is introduced by not letting the donor in-
take lactate. This asymmetry is also sufficient to drive, even
when an unbiased statistical picture of the solution space is
considered, a net lactate exchange as the typical behaviour
Both cells, however, produce a factor 6 (roughly) less ATP
than the maximum possible, given the glucose influx. Despite
a similar overall ATP production profile, the internal fluxes
of donor and acceptor differ significantly. While the donor
distributes glucose almost evenly through LDH and PDHm,
the acceptor can only generate ATP via OXPHOS, since it
intakes lactate as an extra source of carbon. In Supplemen-
tary Fig. S1, we show that two symmetric cells with unbiased
ATP production show identical glucose intake, ATP produc-
tion, and internal flux distribution. Even for symmetric cells,
however, when the donor optimizes the ATP production, we
observe lactate shuttling between donor and acceptor cells, as
illustrated again by Supplementary Fig. S1. In summary, for
maximal ATP production (β → ∞) there is no difference be-
tween ATP production and internal flux distributions of sym-
metric and asymmetric cells-couples. For simplicity in the
analysis of the data, we used the asymmetric case where the
donor cell cannot intake lactate.
We observe that the fraction of ATP produced via oxidative
phosphorylation utilized by the acceptor cell differs substan-
tially from the one of the donor cell. In Fig. 4d we display
the relative usage of the fermentative and the oxidative path-
way and observe that, for low glucose supply, the acceptor cell
8FIG. 6. Oxidative and fermentative fluxes in a donor-acceptor system. (a)–(b) Average flux through LDH (circles) and PDHm (crosses) as
a function of the average glucose supplied to the two-cell system. (c)–(d) Fraction of ATP produced via glycolysis (circles) or via oxidative
phosphorylation (crosses) as a function of the total ATP produced by the donor cell. Pathways are normalized by the “pyruvate-equivalent”, i.e.
by the sum of lactate and half-glucose intakes. Curves describe the behaviour obtained for two coupled HCCN cells with an ATP-maximizing
donor (black lines, β = 50), a loosely maximizing donor (red lines, β = 5) or for an unbiased sampling of the two-cell solution space (blue
lines, β = 0). Error bars, which represents s.e.m., are smaller than symbol sizes.
only employs the oxidative pathway, independent of whether
the donor cell maximizes ATP or not. When the donor cell
maximizes ATP production, it sequesters most glucose and
the acceptor cell is therefore forced to feed on lactate, which
can only be usefully converted to ATP by means of OXPHOS.
Conversely, when the donor cell does not maximize ATP pro-
duction, it secretes a sizable amount of lactate because its
metabolism is inefficient. The lactate acceptor, however, is
also mainly feeding on glucose (see Fig. 5a) and could in prin-
ciple secrete lactate just like the donor cell. The reason why a
purely oxidative metabolism is observed lies in the reversibil-
ity of LDH. Although lactate intake by the acceptor is small,
it suffices to force the pyruvate flux towards TCA and OX-
PHOS, thereby making the acceptor more efficient than the
donor in energetic terms.
In order to assess the robustness of the occurrence of lactate
overflow metabolism under the imposed constraints, we have
further analyzed the flux configurations in a dono/acceptor
system in which the donor maximizes the production of
biomass precursors. We show here (see Fig. 7) results ob-
tained by maximizing the biomass defined as in Table S9,
which essentially reproduce those described above. Such a
robustness becomes less surprising in the light of the fact that
the qualitative features of the switch from oxidative to non-
oxidative metabolism are obtained even in an unbiased sam-
FIG. 7. Donor’s biomass flux and lactate overflow, and accep-
tor’s lactate intake for two coupled HCCNs with a biomass-
maximizing donor. The qualitative behavior obtained when the
donor is maximizing the ATP flux is reproduced in a more realis-
tic case in which a biomass objective function is considered. See
Table S9 for the biomass coefficients.
pling of the steady states. This observation suggets that such
a scenario is to a large degree embedded in the stoichiometry
and in the main topological features of the underlying reaction
network.
9Correlation coefficients among metabolic fluxes of two cells
coupled by lactate shuttle under glucose limitation
To formally assess the extent of metabolic coupling be-
tween an ATP-maximizing lactate donor and a lactate accep-
tor, we computed the matrix of normalized Pearson correla-
tion coefficients of each pair of fluxes in the solutions sampled
for different levels UG of the glucose supplied to the system.
The Pearson coefficient between random variables X and Y
is defined as r = cov(X,Y )/(σXσY ), where cov(X,Y ) de-
notes their covariance and σX and σY stand for their respec-
tive standard deviations. r ranges from −1 to 1 and quantifies
the linear dependence of the two variables. More precisely,
the linear correlation between variablesX and Y is more pos-
itive the closer r is to 1, and more negative the closer r is to
−1, while X and Y can be considered uncorrelated if r ' 0.
For sakes of clarity, we have considered the correlations aris-
ing in a system formed by an ATP-maximizing lactate donor
(large β) and a lactate acceptor. For smaller values of β corre-
lations get weaker while maintaing the same qualitative struc-
ture. Fig. 8 displays three reduced correlation matrices (ob-
tained for three different values of the overall glucose supply)
where only a small subset of fluxes (each presentative of a
different biologically relevant pathway) appears. Full matri-
ces for three choices of UG are instead shown in Figs. S3–S5.
Intuitively, correlation patterns should depend strongly on
UG. The essence of this dependence, which clearly emerges
from Fig. 8, is that cross-correlations between donor and ac-
ceptor build-up as the glucose supply increases, are maximal
when the acceptor’s energetics depends on donor-derived lac-
tate, and then decrease again rapidly to zero when the glucose
supply is large enough to sustain both cells.
If UG is low (sub-threshold for lactate overflow), the
ATP-maximizing donor necessarily outcompetes the accep-
tor for the available glucose, establishing a degree of cross-
correlations that is driven mainly by the unbalanced nutrient
partitioning. The donor indeed employs OXPHOS almost ex-
clusively, while still leaking out a small amount of lactate
which is taken up by the acceptor (i.e. there is no accumu-
lation in the tissue). This suffices to establish the overall cor-
relation among cells that can be seen in Fig. 8a.
As the glucose supply is increased further (above thresh-
old for lactate overflow), the ATP-maximizing donor switches
to aerobic glycolysis and secretes lactate that is shuttled to
the acceptor in large amounts (viz. the strong negative cor-
relation arising between the donor’s lactate outflux and the
acceptor’s lactate influx). In such conditions, the overall
cross-correlations increase, see Fig. 8b. In particular, gly-
colytic fluxes in donor and acceptor anti-correlate, oxidative
pathways weakly anti-correlate, while te donor’s biosynthetic
pathways correlate weakly with the acceptor’s oxidative path-
ways. Notice also that ATP flux in the donor weakly anticor-
relates with every pathway in the acceptor’s metabolism.
At high enough UG, finally, cross-correlations decay as
both cells can rely entirely on glucose for their energetics.
Because the maximum glucose uptake for an HCCN is given
FIG. 8. Restricted matrices of Pearson correlation coefficients
for two coupled HCCN cells when the lactate donor maximizes
the ATP production and the overall glucose supply is large shows
that the two cells are not correlated. The intensity of the color rep-
resents the magnitude of the correlation coefficient (see scale on the
right hand side). The two cells can independently access glucose and
internal fluxes of the lactate acceptor and donor are essentially un-
correlated. The four representative reactions displayed for each cell
are the glucose influx (Glc, a proxy for glycolytic activity), LDH (a
proxy for lactate overflow and exchange), PDH (a proxy for oxidative
metabolism) and the ATP production flux (ATP).
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by UmaxG = ΦATP/ (aG + 2aLDH) (this is determined by the
crowding constraint (25) when glucose is entirely channeled
to fermentation, i.e. when fHEX = UG,don = fLDH/2), one
may assume that UG is “large enough” when it is larger than
2UmaxG , as both cells would in this case have access to as much
glucose as they can intake. In this case, no donor-acceptor
correlations should be expected. Fig. 8c shows that this is in-
deed the case: intra-cellular correlations, described by the di-
agonal blocks, greatly exceed inter-cellular ones (off-diagonal
blocks).
In summary, when glucose availability is limited, the fast-
growing donor necessarily outcompetes the acceptor for glu-
cose and a network of cross-correlations is established be-
tween the metabolic systems of the two cells. Metabolic path-
ways in donor and acceptor correlated however most strongly
when a lactate exchange from donor to acceptor is established,
and decay again as the two cells become effectively decoupled
in glucose-rich media. The build-up of a metabolic partner-
ship is perhaps best seen by the fact that the donor’s glucose
influx UG,don develops a correlation with the acceptor’s LDH
flux at intermediate values of UG. Note also that UG,don cor-
relates more and more strongly with the donor’s LDH flux as
UG increases.
DISCUSSION
Experimental evidence on lactate shuttles in cancer
While lactate shuttling is a likely scenario in many physi-
ological conditions, from muscle cells undergoing intense ac-
tivity [22] to neuron-glia energetics [23–26], and has been re-
ported to take place intra-cellularly at the mitochondrial and
peroxisomal membrane [22], no direct measurement of inter-
cellular lactate exchange in cancer exists. Strong indirect evi-
dence, however, suggests that such a scenario is indeed plau-
sible.
Indeed, tumor-stroma and tumor-tumor metabolic inter-
actions are currently being characterized at various levels.
The emerging picture increasingly suggests that cancer sus-
tainment is a non-cell-autonomous phenomenon [27–30] and
that stromal cells might be potential targets for cancer treat-
ment [31]. Lactate exchange in particular has been investi-
gated both as fueling oxidative cancer cells and as support-
ing non-aberrant cancer-associated cells [32, 33]. The latter
case corresponds to the model discussed here. Signatures of
tumor-to-stroma lactate shuttle have been reported in terms of
the over-expression of monocarboxylate lactate transporters
jointly with increased PDH activity in cancer-associated fi-
broblasts (CAFs) [19, 34]. Likewise, tumor-derived lactate
has been found to play a major signaling role (specifically,
for the initiation of tumor angiogenesis) in vascular endothe-
lial cells [35]. Inhibition of the lactate transporter MCT1 has
therefore been proposed as a possible anti-angiogenic strategy
[36].
Taken together, these observations suggest that tumor cells
and their associated stromal and vessel cells can be seen as
a collective, synergistic metabolic unit where each compart-
ment carries out complementary functions reflected in their
energetic strategies. In such a microenvironment, aerobic stro-
mal cells serve an essential ‘bioremediative’ role by remov-
ing potentially toxic compounds, thereby reducing acidity and
positively feeding back on anaerobic cancer growth. The ex-
istence of a consistent imbalance in energetic demands across
different compartments is crucial to establish this scenario.
Intercellular shuttling of lactate towards oxidative cancer
cells is known to occur in two distinct forms, namely either
from non-oxidative (e.g. hypoxic) to oxidative tumor cells
[36] or through the ‘reverse Warburg effect’, i.e. the onset
of aerobic glycolysis in CAFs [37–41]. The former case de-
scribes the metabolic sysmbiosis that is established e.g. be-
tween more and less hypoxic regions of a tumor, which puta-
tively allows glucose to be delivered more efficiently to more
hypoxic regions [42] (see [43] for a game-theoretic approach
to modeling this kind of tumor-tumor interplay). In the lat-
ter scenario, cancer cells induce oxidative stress in CAFs, re-
sulting in CAFs switching to anaerobic glycolysis [44]. The
secreted lactate is then imported by cancer cells for use in aer-
obic pathways. This effect has indeed been observed in vitro
[39, 41], and its relevance in vivo is currently under scrutiny
[38]. Clearly, however, this type of shuttling is not necessarily
triggered by a strong imbalance in energetic demands between
the lactate donor and acceptor cells, and different constraints
in metabolic activity are likely to be required to understand its
origin within genome-scale models.
It is worth noting that recently developed microfluidic plat-
forms allow to probe the tumor microenvironment with un-
precedented resolution and control over nutrient supply [45].
More light will hopefully be shed on its activity as a functional
metabolic assembly and on the role of lactate in specific.
Going beyond cancer, however, such studies highlight the
fact that replacing the natural environment in which cells live
with a cell culture that is possibly optimized for the cell’s
needs might severely limit our ability to understand the ac-
tual behavior of the system in vivo. On the other hand, they
suggest that cell-autonomous models may be unable to cap-
ture some essential features of the energetics of cells: when
cells employing different energetic demands share a limited
resource, a mutually beneficial microenvironment character-
ized by a large-scale exchange of chemical species can be es-
tablished. A thorough understanding of cellular growth strate-
gies should take these aspects into account.
Conclusions
In this article we have studied the lactate-driven coupling
that is established between cells with different energetic re-
quirements, showing that a lactate shuttle appears robustly
as a consequence of basic physico-chemical constraints. Our
model covers time scales over which the cellular metabolic
networks have to adapt to the establishment of an imbalance
in energy demands (as well as, for instance, in the levels of
main carbon transporters), which are much shorter than the
time required to alter the nutrient availability profile signifi-
cantly (e.g. via vascularization). We have illustrated the emer-
gent metabolic interaction scenario in a simplified model that
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captures the essential fact that, for two such cells, recycling
fermentation products may be a good strategy to optimize cel-
lular glucose usage. To reach these conclusions, we have con-
sidered a human metabolic network model of cells interacting
via lactate shuttle and sampled its feasible metabolic states ac-
cording to a prescribed probability distribution by which we
can tune the degree to which one of the two cells is pushing
its ATP production. The scenario obtained in a highly sim-
plified (but exactly solvable) model is fully retrieved in this
case, where a thorough analysis of correlation patterns reveals
further details of the cell-to-cell coupling.
Such a coupling would have serious physiological implica-
tions. First, lactate recycling implies that lactate may accu-
mulate in tissues only in late-stage tumors. Before neighbor-
ing cells saturate their processing capabilities, the lactate ex-
pelled by cancer cells would be taken in by non-aberrant cells,
suggesting that localized lactate measurements might identify
early-stage tumors. Second, lactate shuttling and recycling
systems should be regarded as potential targets for treatment.
There are many aspects of the approach presented here
that can be further dissected. First is the nature of con-
straints. From a physical point of view, imposing “volume”
constraints of the type considered here is equivalent to impos-
ing finite flux capacities on energy-efficient pathways. There
are however strong indications that unicellular organisms ac-
tively down-regulate energy-efficient pathways at high nutri-
ent levels [46, 47]. The fact that cells invest energy and re-
sources in silencing the synthesis of enzymes involved in aer-
obic pathways suggests that the switch to an energy-inefficient
pathway provides a real, physiological advantage for the cell.
Its origin and nature are currently not understood, although the
inclusion of additional “costs” due to regulation in metabolic
models strongly suggests that the observed phenomenology
can be captured, at least to some degree, by accounting for the
fact that a shift in energetic strategy requires a sizeable change
of a cell’s protein repertoire [1].
It is also important to note that the ETC in eukaryotes
takes place in a separate cellular compartment (the mitochon-
drion), at odds with prokaryotes like bacteria, where it oc-
curs is the cell’s periplasm. We have entirely neglected the
complications due to spatial organization, which is reasonable
as long as one wants to focus on the ATP yield of energy-
producing strategies. However, this aspect will become im-
portant for higher-resolution modeling at genome scale. Like-
wise, a more refined spatial modeling will allow for an in sil-
ico analysis of a possible role of intra-cellular lactate shut-
tling in cancer [22]. In brief, the key idea behind this is that
glycolysis-derived lactate could be employed directly as an
additional energy source for mitochondrial oxidation instead
of being excreted. Elementary biochemical properties of the
LDH reaction indeed would appear to favour lactate (rather
than pyruvate) production in the cytosol. Moreover, experi-
mental facts indicate a possible role of intra-cellular lactate
shuttling in cardiomyocites, neurons and skeletal muscle cells
facing high energy demands [48]. Accounting for it in a com-
putational scheme may help reveal novel details about possi-
ble pathways of energy production during physical exercise or
in rapidly growing cells.
Furtermore, while this work has focused on lactate as a
key mediator of metabolic, energy-driven intercellular inter-
actions, it is worth stressing that recent studies focusing on
the comprehensive analysis of the exometabolome of growing
cells has revealed that metabolic interactions encompass many
more chemical species and is tightly coupled with the growth
regime. In bacteria, for instance, released intermediates in-
clude not only carbon equivalents (like acetate, pyruvate and
ethanol) but also amino acids and central metabolic interme-
diates [like fructose-6-phosphate, glucose-6-phosphate, 2/3-
phosphoglycerates, phosphoenolpyruvate, acetyl-CoA, citrate
and α-ketoglutarate], higher amounts of which have been
found to be consistently released when carbon availability is
high, while intermediates are typically in-taken in carbon-
limitation [2]. Similar interactions are now known to occur
in cancer: leukaemia cells have indeed been recently shown
to employ cysteine derived from bone-marrow stromal cells
as a means to fight oxidative stress [29]. As the scenario un-
derpinning the establishment of such couplings is increasingly
elucidated, it will become possible to set up more refined and
realistic models to capture a greater extent of their physiolog-
ical relevance.
Finally, it should be kept in mind that aerobic glycolysis
in cancer cells, especially at later stages of oncogenic devel-
opment, could be due to the fact that the tumor microenvi-
ronment is hypoxic. The model we consider here addresses
a faster time scale, over which the energy balance of neigh-
bouring cells disrupts while the overall amount of resources
available remains (roughly) unchanged, and suggests that at
these stages tumor-to-stroma metabolic interactions can pro-
vide a mutually beneficial solution to the imbalance. It is also
worth mentioning that cases are known in which malignant
cells rely on increased oxidative phosphorylation rather than
on aerobic glycolysis for energy production (as found, for in-
stance, in transformed human mesenchymal stem cells [5]).
Taken together, these results suggest that cancer’s bioenerget-
ics, starting with the aerobic glycolysis versus oxidative phos-
phorylation “dilemma”, may be a dynamically modulated pro-
cess that differs widely across tumor types [49]
The modeling approach discussed here, based on explor-
ing the solution space induced by mass-balance equations
rather than on optimizing a prescribed objective function, is
in our view the most suited to deal with multi-cell systems
in which extended cell-to-cell metabolic interactions are es-
tablished by one cell’s deregulated metabolic demands. The
sampling method employed here is scalable and easy to im-
plement, providing a highly promising tool for further stud-
ies. It would in particular be important to analyze the emer-
gence of these effects in full-fledged genome-scale models of
specific cancers, as can be obtained e.g. by refining recon-
structions of human metabolic networks with cancer expres-
sion data. The full complexity of metabolic cell-to-cell in-
teractions has only just started to be uncovered. Understand-
ing its functional relevance by detailed in silico models may
provide new insight into the mechanism of cancer progression
and further advance the search of specific, targeted treatments.
It would be important to assess the relevance of lactate shut-
tling in the context of tumors through experiments probing
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metabolism (or metabolite exchanges) directly, rather than by
collecting indirect evidence in the up- or down-regulation of
specific transporters, and metabolic solution space sampling
is known to provide useful keys for experiment design [53].
Our results indicate at least two potential ways to obtain use-
ful information. One possibility requires setting up an assay
where the ability of non-aberrant cells to intake lactate can
be modulated in the presence of bona-fide lactate-secreting
cancer cells. Such a modulation could be achieved, for in-
stance, by either varying the relative concentration of donor-
and acceptor-cells, or by changing the expression of lactate
and glucose transporters in supporting cells. It is reasonable to
expect that, in such a setup, the extracellular acidification rate
due to the accumulation of lactate in the extracellular medium
should negatively correlate with the lactate removal capacity
of the supporting cells. On the other hand, results from our
statistical sampling of the solution space suggest that differ-
ent pathways (and hence, likely, the expression levels of dif-
ferent enzymes) should be tuned in a specific way by chang-
ing the overall glucose supply in a mixed culture shared by
aberrant and non-aberrant cells. Monitoring expression lev-
els in different, controlled nutrient conditions would therefore
provide key validation to the coupling picture discussed here
(and, more generally, to any cell-to-cell coupling scenario for
cancer sustainment).
MATERIALS AND METHODS
Human core catabolic network for a single cell
We built a realistic metabolic network of ATP production
from the decompartmentalized human reactome Recon-1 [21]
that we use throughout the manuscript. (While the more re-
cent Recon-2 reactome [50] provides a higher resolution re-
construction of human metabolism, the degree of detail pro-
vided by Recon-1 more than suffices for our purposes.) The
HCCN includes the following Recon-1 pathways: Glycolysis,
Pentose Phosphate Pathway, Citric Acid Cycle, and Oxidative
Phosphorylation. In addition, we included anabolic pathways
for the production of biomass precursors (amino acids and
fatty acids) in an effective way. Details of the reconstructed
network are given in Supporting Text S1. We then proceeded
by removing the leaves of the resulting network (a necessary
pre-processing step required to implement the mass-balance
constraints described below). To rid the model of a priori in-
feasible loops, we resorted to the method described in [51].
A single infeasible cycle was identified, which was fixed by
leaving only one of the two isoforms of the isocitrate dehy-
drogenase that uses NADP as cofactor.
The final HCCN we employed in this study is composed
of 67 chemical species (listed in Table S2) and 75 reactions
(listed in Tables S3 and S4), including the uptake/secretion
of 11 metabolites (namely molecular oxygen, carbon dioxide,
water, hydrogen, lactate, glucose, ammonia, phenylalanine,
methionine, glutamine, and methyl group—which represents
a generic methylation–whose bounds are fixed as described
in Table S5), and reactions consuming ATP, aminoacids and
palmitic acid. Among intracellular reactions, 23 are reversible
according to Recon-1’s thermodynamic assignments. We have
considered a medium with variable maximum glucose in-
take, fixed maximum glutamine intake and unbounded oxygen
availability. Finally, ATP consumption presents a lower bound
standing for the minimum ATP consumption flux fminATP nec-
essary for cell survival (the bounds of all reactions are listed
in Table S6 and S7).
Human core catabolic network for two coupled cells
In order to analyze the coupling of two identical cells, we
simply replicated the HCCN twice, the only difference ly-
ing in the uptake reaction for lactate. In specific, the lac-
tate donor can only secrete lactate (through an irreversible
reaction), while the acceptor can both excrete and import
it. The coupling is ultimately determined by the partition-
ing of glucose and by the shuttling of lactate. The former
is a shared resource, while the latter can be exchanged be-
tween the two cells: both cells can produce lactate, but there
is no external source of lactate. We have included two fur-
ther constraints for the sum of glucose and lactate flux of
the donor-acceptor system, i.e., UG,don + UG,acc ≤ UG and
ULAC,don + ULAC,acc ≥ 0 (see Table S8). As for a single
HCCN, glucose can only be imported while lactate can only
be excreted.
Crowding constraint for the human core catabolic network
The crowding constraint within the HCCN has been imple-
mented as
aglycfHEX + aox(fPDH+fGLUN) + aLDHfLDH ≤ ΦATP
(27)
where fHEX denotes the Hexokinase-1 flux, fPDH denotes
the flux through pyruvate dehydrogenase, by which pyruvate
is diverted into the TCA cycle, and fGLUN denotes the flux
through glutaminase. For aglyc, aLDH and aPDH we use the
numerical values given in [14] for a coarse-grained model,
since for unitary flux both fHEX and fox transport the same
amount of carbons present in glucose, which is exactly what
the effective fluxes defined in [14] do.
Inequality (27) is valid for a cell that excretes lactate. When
lactate can also be intaken, as occurs for the coupled HCCN
cells, the flux through LDH can become negative. The more
general form of the crowding constraint we consider is there-
fore
aglycfHEX + aox(fPDH + fGLUN) + aLDH|fLDH| ≤ ΦATP.
(28)
For both the single HCCN and the two-HCCN models, we
provide as supplementary materials files containing the lists
of metabolites and reactions (with bounds), and the explicit
expressions of each reaction in the HCCN in terms of inde-
pendent variables, which provide a full characterization of
the solution space polytope. The files can also be down-
loaded from http://chimera.roma1.infn.it/SYSBIO, where an
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SBML file with the model and a text file with the stoichio-
metric matrix of the single cell HCCN are also made avail-
able. HCCN for a single cell has also been deposited in
BioModels Database (biomodels.org) and assigned the identi-
fier MODEL1506170000.
Representation of the solution space of constraint-based
metabolic networks as a convex polytope
In mass-balance setups, a set of reaction fluxes f = {fr}
(r = 1, . . . , N ) describes a non-equilibrium stationary state if
it satisfies the conditions
N∑
r=1
Srmfr = 0 , m = 1, . . . ,M , (29)
with prescribed bounds f−r ≤ fr ≤ f+r . (Clearly, the zero
flux vector is excluded from these considerations.) Here,
Srm denotes the stoichiometric index of chemical species m
(m = 1, . . .M ) in reaction r. From a geometric viewpoint,
(29) defines a convex polytope, while every point inside it
represents a feasible flux configuration. In absence of criteria
allowing to select specific flux vectors from the solution space
(e.g. via the maximization of an objective function), uniform
sampling provides important information about average fluxes
and correlations that not only describe the viable flux patterns
in statistical terms, but may also give relevant guidelines for
designing experiments [52]. When the dimension of the so-
lution space is sufficiently small (typically around 10), Monte
Carlo sampling, including straightforward rejection methods
[53], can be applied. At higher dimensions, instead, exceeding
computing times require the use of more advanced techniques.
Dimensional reduction of the solution space
We are interested in sampling the solution space of (29)
with S = {Srm} given by the HCCN with the prescribed
probability measure defined in (26). Mass balance conditions
constrain many of the 75 fluxes to be dependent on other vari-
ables. To explore efficiently the space of viable flux config-
urations, it is convenient to solve all such dependencies ana-
lytically and then sample the (much smaller) space spanned
by independent fluxes. To begin with, we transformed S to its
Reduced Row Echelon Form (RREF) through Gauss-Jordan
elimination , which can be implemented by standard pack-
ages. Because the RREF of any matrix is unique, the RREF
of the stoichiometric matrix applied to the reaction network
uniquely represents the dependent fluxes as a function of the
independent ones. The single-HCCN model turns out to have
only 17 independent variables, while the two-HCCN version
has 34. These numbers also represent the dimensionsD of the
respective solution space polytopes.
Hit-and-run method allows to sample convex polytopes
efficiently
The Hit-and-Run (HR) method [54, 55] can uniformly and
efficiently sample a convex polytope, provided one starts from
a point inside it. The problem of finding such a point can be
easily solved, e.g., via Motzkin relaxation [51, 56]. In brief,
HR builds a Markov chain in two steps. First, starting from
a point inside the polytope, a random direction is extracted.
Second, along this direction a new point is chosen uniformly
at random inside the polytope. The scheme is then iterated
starting from the new internal point. HR is efficient because
once the random direction is generated the search space is re-
duced to a segment. In our implementation, we generate the
random direction using the Marsaglia-Bray method [57]. To
pick a point at random along the segment, instead, we first
compute the two intersections with the polytope and then ex-
tract a uniform random number inside the segment identified
by these two points on the line.
The Lovasz method speeds up the sampling of heterogeneous
polytopes
The above procedure, while fully exact, may however
present a drawback in concrete cases. In fact, the mixing
time of HR in convex domains scales asO[D2(R/r)2] Monte
Carlo steps, where D is the spatial dimension of the poly-
tope while r and R are, respectively, the radius of the max-
imum inscribed hypersphere and of the minimum circum-
scribed hypersphere [58]. It is clear that the R/r factor can
increase convergence times dramatically for strongly hetero-
geneous polytopes. This is precisely the case for the space
of feasible steady states in a large-scale metabolic network,
where flux distributions can be so heterogeneous as to span
5 orders of magnitudes [59–61]. For the network analyzed
here, the ratio between the ellipsoid’s longest and smallest
axes turned out to be of order 104, leading to a condition
number of order R2/r2 ' 108, a value that would render
straightforward HR too expensive in terms of CPU time. To
circumvent this ill-conditioning problem, we have resorted to
a standard pre-processing step that identifies the ellipsoid that
best approximates the shape of the polytope [62]. Extracting
vectors uniformly on such an ellipsoid guarantees that the di-
rections along the longer axis are chosen more often, thereby
removing ill conditioning. In quantitative terms, such a pre-
processing gives HR a mixing time of O[D7/2] Monte Carlo
steps, thus implying a fully polynomial scaling with D. After
pre-processing the slowest HR mode was found to decorre-
late in an affordable time of O(104) Monte Carlo steps. Fur-
thermore, the overall pre-processing time was negligible com-
pared to the time spent for the actual solution space sampling,
while the center of the ellipsoid provides an excellent starting
point for the algorithm. For more details of this method we
refer the reader to [63].
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A method for tuning the optimization of a given metabolic flux
for constrained based metabolic networks
HR is easily modified to sample points according to any
given flux distribution P (f) by imposing that the selection
of points along the segment takes place according to how
the distribution P projects onto the chosen direction rather
than uniformly. To modulate P via a linear function L(f) of
the fluxes, it is convenient to use the Boltzmann distribution
P (f) ∝ exp [βL(f)], where β ≥ 0 is an interpolation pa-
rameter. By varying β, one passes from an uniform sampling
(corresponding to β = 0) to sampling flux configurations that
maximize L(f) (corresponding to β  1). For the HCCN
network studied here, the ATP production fATP is maximized
using the above method with P (f) ∝ exp [βfATP ]. The value
of β for which fATP is effectively maximized can be deter-
mined numerically. In Fig. S6 we plot the ATP production as
a function of the β for five different values of the maximal
glucose available for two coupled HCCN cells. One sees that
optimal fATP is already achieved when β ' 50.
To produce the graphs presented in Figs. 4 through 8 and
S1 through S6, we applied the Lovasz method to the reduced
row echelon forms of the HCCN networks and sampled the
corresponding regularized polytopes by means of the Hit-and-
run method. For curves with β 6= 0, we used the Boltzman
weight presented above. The apply the Lovasz method and
the uniform and optimized HR sampling, we used C++ pro-
grams that we developed and that can be freely downloaded at
http://chimera.roma1.infn.it/SYSBIO.
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SUPPLEMENTARY TEXT
Text S1. Human Catabolic Core Network: biosynthetic reactions
Besides the major central carbon metabolic pathways, i.e. Glycolysis, Pentose Phosphate Pathway, Citric Acid Cycle, and
Oxidative Phosphorylation, our model includes most reactions of Glutamate metabolism as well as lumped reactions describing
the biosynthesis of all non-essential amino acids (i.e. the amino acids that can be synthesized by human cells) and palmitate, a
key precursor of other fatty acids.
Amino acid biosynthetic processes can be divided roughly in two classes. The synthesis of tyrosine and cysteine requires
respectively the essential amino acids phenylalanine and methionine. All other amino acids can instead be synthetized from
glutamine plus metabolites from the central carbon pathways. The processes leading to amino acid synthesis are of various
types, from simple single transaminase reactions to a complex chain of enzymatic reactions. In the latter case, by means of mass
balance arguments we can lump together individual reaction steps to obtain effective reactions whose net output corresponds to
the desired amino acid(s). In all cases, our starting points were the reactions and pathways included in the reference metabolic
network reconstruction Recon-1 [21]. In the .xml file provided as Supporting Material, we include the list of the corresponding
Recon-1 reactions that constitute the full pathway. In the following, we briefly outline these effective reactions.
• Glutamate synthesis: from glutamine via glutaminase (GLUN):
gln L + H2O→ glu L + NH4 (30)
• Alanine and aspartate synthesis: from glutamate through the transaminase reactions
akg + ala L↔ glu L + pyr (31)
akg + asp L↔ glu L + oaa (32)
(akg = α-ketoglutarate ; pyr = pyruvate ; oaa = oxaloacetate)
• Proline synthesis: from glutamate via glutamate 5-kinase (GLU5K), glutamate-5-semialdehyde dehydrogenase (G5SD),
L-glutamate 5-semialdehyde dehydratase (G5SAD) and pyrroline-5-carboxylate reductase (P5CR):
glu L + ATP + (2)NADPH + (2)H+ → pro L + ADP + Pi + H2O + (2)NADP (33)
• Serine synthesis: from glutamate via phosphoglycerate dehydrogenase (PGCD), phosphoserine transaminase (PSERT)
and phosphoserine phosphatase (PSP):
3pg + NAD + H2O + glu L→ ser L + akg + NADH + Pi + H+ (34)
(3pg = 3-phosphoglyceric acid)
• Glycine synthesis: from serinevia glycine hydroxymethyltransferase (GHMT), methylenetetrahydrofolate dehydrogenase
(MTHFD), methenyltetrahydrofolate cyclohydrolase (MTHFC) and formyltetrahydrofolate dehydrogenase (FDH):
ser L + H2O + (2)NADP→ gly + CO2 + (2)NADPH + (2)H+ (35)
• Arginine synthesis: from glutamate and aspartate via glutamate 5-kinase (GLU5K), glutamate-5-semialdehyde dehydroge-
nase (G5SD), ornithine transaminase (ORNTA), carbamoyl-phosphate synthase (CBPS), ornithine carbamoyltransferase
(OCBT), argininosuccinate synthase (ARGSS) and argininosuccinate lyase (ARGSL):
asp L + glu L + gln L + (5)ATP + NADPH + (3)H2O + CO2 →
→ arg L + fum + akg + (5)ADP + (5)Pi + NADP + (5)H+ (36)
• Asparagine synthesis: from aspartate and glutamine via asparagine synthase (ASNS):
asp L + (2)ATP + gln L + (2)H2O→ (2)ADP + asn L + glu + (2)H+ + (2)Pi (37)
• Cysteine synthesis: from serine and methionine via methionine adenosyltransferase (METAT), adenosylhomocys-
teinase (AHC), cystathionine beta-synthase (CBS), cystathionine gamma-lyase (CSE), 2-Oxobutanoate dehydrogenase,
Propionyl-CoA carboxylase (PCCA) and methylmalonyl-CoA mutase (MMM):
met L + ser L + coa + (4)ATP + NAD + (4)H2O→
→ cys L + succoa + (4)ADP + (4)Pi + (4)H+ + NADH + NH4 + CH3 (38)
(coa = coenzyme A ; succoa = succinyl-coa)
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• Tyrosine synthesis: from phenylalanine via L-Phenylalanine hydroxylase, tetrahydrobiopterin oxidoreductase,
tetrahydrobiopterin-4a-carbinolamine dehydratase and dihydropteridine reductase:
phe L + NADH + O2 + H+ → tyr L + NAD + H2O (39)
• Palmitic acid synthesis:
(8)accoa + (23)ATP + (14)NADPH + (17)H2O→
→ palmitate + (8)coa + (14)NADP + (23)ADP + (23)Pi + (10)H+ (40)
(accoa = acetyl-coa)
In addition, we included the reactions for superoxyde reduction and FADH2 oxidation, that are necessary to correctly account
for the redox state of the cell. For sakes of simplicity, we lumped together the reactions catalyzed by superoxide dismutase,
gluthatione peroxidase and glutathione reductase to the single reaction
NADPH + O−2 + 2H
+ → NADP + 2H2O . (41)
Likewise, we unified the two reactions that oxidate FADH2, thereby reducing ubiquinone by means of the Electron transport
flavoprotein-ubiquinone oxidoreductase (ETF) to
FADH2 + Q10→ FAD + Q10H2 . (42)
Text S2. Maximizing the flux of precursors: results
In the main text, we show that lactate overflow and shuttle arises under both biomass and ATP maximization. Here, we show
the metabolic flux patterns obtained when in the lactate donor the production of single biomass precursors are maximized, to
assess the robustness of the lactate overflow and shuttle. To limit the amino acid productions, we have assumed a fixed maximum
total influx of glutamine, phenylalanine and methionine (equals to 2 mmol/(gDWh)) and a variable overall glucose supply.
All objective functions we tested yield a lactate overflow with lactate shuttle towards the acceptor, suggesting that the crowding
constraint is responsible for the effect. In particular, we recover high levels of lactate shuttling for palmitate optimization and
moderate levels for the optimization of the production of amino acids. The only lactate shuttle truly related to an energetic
imbalance is the one induced by palmitate optimization, while the others are similar in magnitude to the shuttling present in
the absence of any optimization (i.e. for β = 0). In Fig. S2, we display the production flux and lactate shuttling profiles as a
function of the total glucose supply for the two-cell system when the lactate donor maximizes palmitate, proline, cysteine, and
serine, respectively. Other biosynthetic objective functions lead to similar features.
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FIG. S1. Glucose intake, ATP production, and oxidative and fermentative fluxes in a donor-acceptor symmetric system. (a, top left)
Glucose intakes for two coupled symmetric cells as a function of the total glucose available to the donor-acceptor pair. (b, top right) ATP
produced by the donor and the acceptor cells as a function of the total glucose available to the donor-acceptor pair. (c, bottom left)–(d, bottom
right) Average flux through LDH (circles) and PDHm (crosses) as a function of the average glucose supplied to the two-cell system. Curves
describe the behaviour obtained for two coupled symmetric HCCN cells with an ATP-maximizing donor (black lines, β = 50) or for an
unbiased sampling of the two-cell solution space (blue lines, β = 0). Error bars, which represents s.e.m., are smaller than symbol sizes.
FIG. S2. Lactate shuttling for alternative objective function maximizations. In blue we plot the flux that is maximized in the donor cell:
palmitate (top left), proline (top right), cysteine (bottom left), and serine (bottom right) as a function of the total glucose supply, for a system
formed by a lactate donor and a lactate acceptor. The lactate fluxes of donor and acceptor cells are depicted in green and red, respectively. A
negative flux correspond to lactate influx.
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FIG. S3. Pearson correlation coefficients among all fluxes of lactate donor and lactate acceptor for maximum glucose uptake UG = 0.3.
The fluxes of the acceptor cell are identified by the trailing letters “acc”.
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FIG. S4. Pearson correlation coefficients among all fluxes of lactate donor and lactate acceptor for maximum glucose uptake UG = 1.
The fluxes of the acceptor cell are identified by the trailing letters “acc”.
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FIG. S5. Pearson correlation coefficients among all fluxes of lactate donor and lactate acceptor for maximum glucose uptake UG = 3.
The fluxes of the acceptor cell are identified by the trailing letters “acc”.
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FIG. S6. By increasing β, an HCCN increases the ATP production eventually saturating the capacity at around β ' 50. We display
normalized ATP production fluxes for maximal glucose supply UMAX equals to 0.5 (black circels), 1 (red squares), and 5 (blu diamonds).
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SUPPLEMENTARY TABLES
Variable symbol Flux identified
UG Glucose supply
fglyc, fHEX Glycolysis flux
fox, fPDH Oxidative phosphorylation flux
fLDH Flux through lactate dehydrogenase
fATP ATP production
TABLE S1. List of more relevant variables appearing in the manuscript.
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Metabolite short name Metabolite extended name
13 DPG 3-Phospho-D-glyceroyl phosphate
23 DPG 2,3-Disphospho-D-glycerate
2 PG D-Glycerate 2-phosphate
3 PG 3-Phospho-D-glycerate
6 PGC 6-Phospho-D-gluconate
6 PGL 6-phospho-D-glucono-1,5-lactone
ACCoA Acetyl-CoA
ADP Adenosine diphosphate
AKG 2-Oxoglutarate
ATP Adenosine triphosphate
CIT Citrate
CO2 Carbon dioxyde
CoA Coenzyme A
DHAP Dihydroxyacetone phosphate
E4 P D-Erythrose 4-phosphate
F6 P D-Fructose 6-phosphate
FAD Flavin adenine dinucleotide oxidized
FADH2 Flavin adenine dinucleotide reduced
FDP D-Fructose 1,6-bisphosphate
FICYTC Ferricytochrome C
FOCYTC Ferrocytochrome C
FUM Fumarate
G3 P Glyceraldehyde 3-phosphate
G6 P D-Glucose 6-phosphate
GLC D-Glucose
H2O Water molecule
H[M] Hydrogen ion as an electromotive force (mitochondrial)
H Hydrogen ion in cytoplasm
ICIT Isocitrate
LAC−L L-Lactate
MAL−L L-Malate
NAD Nicotinamide adenine dinucleotide
NADH Nicotinamide adenine dinucleotide - reduced
NADP Nicotinamide adenine dinucleotide phosphate
NADPH Nicotinamide adenine dinucleotide phosphate - reduced
O2 Molecular oxygen
O2S Superoxide anion
OAA Oxaloacetate
PEP Phosphoenolpyruvate
Pi Phosphate
PYR Pyruvate
Q10 Ubiquinone-10
Q10 H2 Ubiquinol-10
R5 P alpha-D-Ribose 5-phosphate
RU5 P−D D-Ribulose 5-phosphate
S7 P Sedoheptulose 7-phosphate
SUCC Succinate
SUCCoA Succinyl-CoA
XU5 P−D D-Xylulose 5-phosphate
gln L Glutamine
glu L Glutamate
NH4 Ammonia
CH3 Methil group
asp L Aspartate
ala L Alanine
asn L Asparagine
pro L Proline
ser L Serine
gly Glycine
arg L Arginine
cys L Cysteine
met L Methionine
tyr L Tyrosine
phe L Phenylalanine
hdca Palmitic acid
TABLE S2. List of metabolites appearing in a single HCCN model.
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Enzyme Reaction
ACONT CIT←→ ICIT
ACYP 13 DPG + H2O −→ 3 PG + H + Pi
AKGDm AKG + CoA + NAD −→ CO2 + NADH + SUCCoA
ATPS4 m ADP + 4 H + Pi −→ ATP + 3 H[M] + H2O
CSm ACCoA + H2O + OAA −→ CIT + CoA + H[M]
CYOOm3 4 focytC + 7.92H[M] + O2 −→ 4 ficytC + 4 H + 1.96H2O + 0.02O–2
CYOR u10m 2 ficytC + 2 H[M] + Q10H2 −→ 2 focytC + 4 H + Q10
DPGM 13 DPG←→ 23 DPG + H
DPGase 23 DPG + H2O −→ 3 PG + Pi
ENO 2 PG←→ H2O + PEP
FBA FDP←→ DHAP + G3 P
FUM FUM + H2O←→ MAL−L
G6PDH2r G6 P + NADP←→ 6 PGL + H + NADPH
GAPD G3 P + NAD + Pi←→ 13 DPG + H + NADH
GND 6 PGC + NADP −→ CO2 + NADPH + RU5 P−D
HEX1 ATP + GLC −→ ADP + G6 P + H
ICDHxm ICIT + NAD −→ AKG + CO2 + NADH
ICDHy ICIT + NADP −→ AKG + CO2 + NADPH
LDH LAC−L + NAD←→ H + NADH + PYR
MDH MAL−L + NAD←→ H + NADH + OAA
NADH2 u10m 5 H + NADH + Q10 −→ 4 H + NAD + Q10 H2
PDHm CoA + NAD + PYR −→ ACCoA + CO2 + NADH
PFK ATP + F6 P −→ ADP + FDP + H
PGI G6 P←→ F6 P
PGK 3 PG + ATP←− 13 DPG + ADP
PGL 6 PGL + H2O −→ 6 PGC + H
PGM 2 PG←→ 3 PG
PYK ADP + H + PEP −→ ATP + PYR
RPE RU5 P−D←→ XU5 P−D
RPI R5 P←→ RU5 P−D
SUCD1m FAD + SUCC←→ FADH2 + FUM
SUCOASm ATP + CoA + SUCC←→ ADP + Pi + SUCCoA
TALA G3 P + S7 P←→ E4 P + F6 P
TKT1 R5 P + XU5 P−D←→ G3 P + S7 P
TKT2 E4 P + XU5 P−D←→ F6 P + G3 P
TPI DHAP←→ G3 P
O2S reduction NADPH + O–2 + 2 H −→ NADP + 2 H2O
FAD regeneration Q10 + FADH2 −→ Q10 H2 + FAD
ATP consumption ATP + H2O −→ ADP + Pi + H
TABLE S3. Internal reactions of an HCCN with the corresponding enzyme that catalyzes it: main catabolic pathways.
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Enzyme Reaction
ALATA L AKG + ala L←→ glu L + PYR
ASPTA AKG + asp L←→ glu L + OAA
GLUDxm glu L + H2O + NAD −→ AKG + H + NADH + NH4
GLUDym glu L + H2O + NADP −→ AKG + H + NADPH + NH4
GLUN gln L + H2O −→ glu L + NH4
Tyrosine production phe L + NADH + O2 + h −→ tyr L + NAD + H2O
Asparagine production asp L + (2)ATP + gln L + (2)H2O −→ (2)ADP + asn L + glu L + (2)H + (2)Pi
Proline production glu L + ATP + (2)NADPH + 2 H
+ −→ pro L + ADP + Pi + H2O + (2)NADP
Serine production 3 PG + NAD + H2O + glu L −→ ser L + AKG + NADH + Pi + H
Glycine production ser L + H2O + (2)NADP −→ gly + CO2 + (2)NADPH + (2)H
Arginine production asp L + glu L + gln L + (5)ATP + NADPH + 3 H2O + CO2 −→arg L + FUM + AKG + (5)ADP + (5)Pi + 5 H + NADP
Cysteine production met L + ser L + COA + (4)ATP + NAD + CO2 + (4)H2O −→cys L + SUCCOA + (4)ADP + (4)Pi + 4 H + NADH + NH4 + CO2 + CH3
Palmitic acid production (8)ACCOA + (23)ATP + 8 NADH + (6)NADPH + 17 H2O −→hdca + (8)COA + (8)NAD + (6)NADP + (23)ADP + (23)Pi + (10)H
TABLE S4. Internal reactions of an HCCN with the corresponding enzyme that catalyzes it: glutamate metabolism and anabolic
effective reactions.
Description Lower bound Upper bound Reaction
Flux of carbon dioxide -1000 1000 CO2←→ out
Flux of oxygen -1000 1000 O2←→ out
Flux of water -1000 1000 H2O←→ out
Flux of ion hydrogen -1000 1000 H←→ out
Glucose intake 0 UG in←− GLC
Lactate flux 0-1000
1000
1000
LAC-L −→ out (donor)
LAC-L←→ out (acceptor)
Glutamine intake 0 1 in←− gln L
Phenylalanine intake 0 1000 in←− phe L
Methionine intake 0 1000 in←− met L
Ammonia flux -1000 1000 NH4 ↔ out
Methyl group flux -1000 1000 CH3 ↔ out
TABLE S5. Exchange reactions of an HCCN with the corresponding bounds. In this model, we assume that carbon dioxide, water, oxygen,
and proton can freely diffuse in and out of the cell. The maximum glucose intake for each cell cannot exceed the total glucose supply. Lactate
flux distinguishes donor and acceptor cells as the donor can only secrete lactate, while the acceptor can also intake lactate. In Table S8, the
constraints on glucose and lactate fluxes for the donor-acceptor couple are presented.
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Enzyme Lower bound Upper bound Enzyme extended name
ACONT -1000 1000 Aconitase
ACYP 0 1000 Acylphosphatase
AKGDm 0 1000 2-Oxoglutarate dehydrogenase
ATPS4m 0 1000 ATP synthase
CSm 0 1000 Citrate synthase
CYOOm3 0 1000 Cytochrome C oxidase, mitochondrial Complex IV
CYOR u10m 0 1000 Ubiquinol-6 cytochrome C reductase, Complex III
DPGM -1000 1000 Diphosphoglyceromutase
DPGase 0 1000 Diphosphoglycerate phosphatase
ENO -1000 1000 Enolase
FBA -1000 1000 Fructose-bisphosphate aldolase
FUM -1000 1000 Fumarase
G6PDH2r -1000 1000 Glucose 6-phosphate dehydrogenase
GAPD -1000 1000 Glyceraldehyde-3-phosphate dehydrogenase
GND 0 1000 Phosphogluconate dehydrogenase
HEX1 0 1000 Hexokinase
ICDHxm 0 1000 Isocitrate dehydrogenase
ICDHy 0 1000 Isocitrate dehydrogenase
LDH -1000 1000 Lactate dehydrogenase
MDH -1000 1000 Malate dehydrogenase
NADH2 u10m 0 1000 NADH dehydrogenase, mitochondrial
PDHm 0 1000 Pyruvate dehydrogenase
PFK 0 1000 Phosphofructokinase
PGI -1000 1000 Glucose-6-phosphate isomerase
PGK -1000 0 Phosphoglycerate kinase
PGL 0 1000 6-phosphogluconolactonase
PGM -1000 1000 Phosphoglycerate mutase
PYK 0 1000 Pyruvate kinase
RPE -1000 1000 Ribulose-5-phosphate 3-epimerase
RPI -1000 1000 Ribose-5-phosphate isomerase
SUCD1m -1000 1000 Succinate dehydrogenase
SUCOASm -1000 1000 Succinate–CoA ligase
TALA -1000 1000 Transaldolase
TKT1 -1000 1000 Transketolase
TKT2 -1000 1000 transketolase
TPI -1000 1000 Triose-phosphate isomerase
Lumped reaction 0 1000 Reduction of superoxyde anion
Lumped reaction 0 1000 FAD regeneration
Effective reaction fminATP 1000 ATP hydrolysis
TABLE S6. Internal reactions of an HCCN with the corresponding bounds: catabolic pathways.
Enzyme Lower bound Upper bound Enzyme extended name
ALATA L -1000 1000 alanine transaminase
ASPTA -1000 1000 aspartate transaminase
GLUDxm -1000 1000 glutamate dehydrogenase (NAD)
GLUDym 0 1000 glutamate dehydrogenase (NADP)
GLUN 0 1000 glutaminase
Lumped reaction 0 1000 Tyrosine production
Lumped reaction 0 1000 Asparagine production
Lumped reaction 0 1000 Proline production
Lumped reaction 0 1000 Serine production
Lumped reaction 0 1000 Glycine production
Lumped reaction 0 1000 Arginine production
Lumped reaction 0 1000 Cysteine production
Lumped reaction 0 1000 Palmitic acid production
TABLE S7. Internal reactions of an HCCN with the corresponding bounds: glutamate metabolism and anabolic effective reactions.
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Variable constrained Lower bound Upper bound Variable expressed by reactions
Donor resource 0 ΦATP aglycfHEX,don + aoxfPDH,don + aLDHfLDH,don
Acceptor resource 0 ΦATP aglycfHEX,acc + aoxfPDH,acc + aLDH|fLDH,acc|
Total glucose intake 0 UG UG,don + UG,acc
Total lactate flux 0 1000 ULAC,don + ULAC,acc
TABLE S8. Constraints on maximum resources available for ATP production and on total glucose and lactate fluxes. The first column
contains a description of the variable that is constrained, while the last column the variable expressed as a function of the elementary fluxes of
the metabolic network. The second and the third column contain the minimum and the maximum value that the variable can take, respectively.
ΦATP is set to 0.4 and states that at most 40% of the cellular resources can be devoted to ATP production. The sum of the glucose intaken by
donor and acceptor cannot exceed the total glucose supply UG. The constraint on total lactate flux establishes that there is no external source
of lactate in the system and that the donor-acceptor couple can only produce lactate.
Metabolite Biomass coefficient
H2O -20.651
ATP -20.651
ADP 20.651
H 20.651
Pi 20.971
glu L -0.38587
asp L -0.35261
asn L -0.27942
ala L -0.50563
cys L -0.046571
gln L -0.326
gly -0.53889
ser L -0.39253
arg L -0.35926
met L -0.15302
tyr L -0.15967
phe L -0.25947
pro L -0.41248
hdca -0.112
R5 P -0.045
G6 P -0.275
TABLE S9. Biomass objective function coefficients adapted from [47].
